...
首页> 外文期刊>Circulation journal >Cardiac Magnetic Resonance Imaging: Choice of the Year – Which Imaging Modality Is Best for Evaluation of Myocardial Ischemia? (MRI-Side) –
【24h】

Cardiac Magnetic Resonance Imaging: Choice of the Year – Which Imaging Modality Is Best for Evaluation of Myocardial Ischemia? (MRI-Side) –

机译:心脏磁共振成像:年度选择–哪种成像方式最适合评估心肌缺血? (MRI端)–

获取原文
           

摘要

The increasing variety of available cardiac imaging techniques have made the investigation of coronary artery disease more complex. On the one hand, nuclear cardiology or myocardial perfusion imaging (MPI) allows accurate and reliable quantitative measurement of myocardial blood flow. On the other hand, a newer technique, cardiac magnetic resonance imaging (CMR) is an attractive alternative for achieving similar purposes without exposing patients to radiation hazards. With a higher spatial resolution, CMR is more sensitive for detecting subendocardial ischemia; small myocardial infarction and/or fibrosis, which cannot be achieved in a nuclear study. Nuclear MPI has dominated clinical practice over the past 3 decades on the basis of an extensive amount of research. More upcoming research on CMR would warrant more evidence-based data of its value for disease diagnosis, prognosis and risk stratification and incorporating it into the clinical diagnostic and management algorithm. ( Circ J 2011; 75: 724-731)
机译:可用的心脏成像技术的多样性不断增加,使冠状动脉疾病的研究更加复杂。一方面,核心脏病学或心肌灌注成像(MPI)可以精确可靠地定量测量心肌血流量。另一方面,心脏磁共振成像(CMR)是一种较新的技术,可以实现相似的目的,而又不会使患者受到辐射危害,是一种有吸引力的选择。 CMR具有更高的空间分辨率,对检测心内膜下局部缺血更加敏感。微小的心肌梗塞和/或纤维化,在核研究中无法实现。在大量研究的基础上,核MPI在过去的30年中一直占据着临床实践的主导地位。即将开展的有关CMR的更多研究将需要更多基于证据的数据来证明其在疾病诊断,预后和风险分层中的价值,并将其纳入临床诊断和管理算法中。 (Circ J 2011; 75:724-731)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号